Company Scinai Immunotherapeutics Ltd.

Equities

SCNI

US09073Q2049

Biotechnology & Medical Research

Analysts' Consensus

Business Summary

Share class

Shareholders

Company contact information

Sector

Quarterly earnings - Rate of surprise

Sector Other Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 04:30:01 2024-04-26 pm EDT			5-day change	1st Jan Change
0.4578 ^USD	+1.74%		-1.76%	-23.11%

Apr. 08	Exchange-Traded Funds, Equity Futures Gain Slightly Pre-Bell Monday as June Rate Cut Likelihood Falls	MT
Apr. 08	Ayana Pharma Selects Scinai Immunotherapeutics' CDMO Unit to Provide Drug Development and cGMP Manufacturing Services	CI

Scinai Immunotherapeutics Ltd, formerly known as BiondVax Pharmaceuticals Ltd is an Israel-based biopharmaceutical company that is principally focused on developing, manufacturing, and commercializing medical products for the prevention and treatment of autoimmune and infectious diseases but also for other illnesses. The Companyâs core focus is to develop NanoAbs for the treatment of various diseases such as COVID-19, psoriasis, and asthma. The Company's product NanoAb is based on alpaca-derived nanosized antibodies (NanoAbs), also known as VHH-antibodies. Additionally, the Company offers manufacturing facilities, aseptic fill and finish suites, laboratories, and experienced professionals for other research and development companies. Scinai Immunotherapeutics Ltd operates in Israel.

Number of employees: 33

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	1,740,770,784	515,957,241 ( 29.64 %)	0	29.64 %

Name	Equities	%	Valuation
Armistice Capital LLC 6.323 %	230,896	6.323 %	119 835 $
Sabby Management LLC 6.042 %	220,663	6.042 %	114 524 $
RhumbLine Advisers LP 0.1455 %	5,314	0.1455 %	2 758 $
Morgan Stanley Capital Services LLC 0.0707 %	2,582	0.0707 %	1 340 $
UBS Securities LLC 0.0498 %	1,817	0.0498 %	943 $
CA Indosuez (Switzerland) SA 0.0116 %	424	0.0116 %	220 $
UBS Financial Services, Inc. 0.008215 %	300	0.008215 %	156 $
The Main Street Group Ltd. 0.005477 %	200	0.005477 %	104 $
Aspire Private Capital LLC 0.004381 %	160	0.004381 %	83 $
Global Retirement Partners LLC 0.001369 %	50	0.001369 %	26 $

Name	Equities	%	Valuation
Daniel Stone 33.41 %	249,600,000	33.41 %	324 480 $
Hitech Ltd. 22.88 %	170,961,600	22.88 %	222 250 $
George Lowell 0.0564 %	421,600	0.0564 %	548 $
Avner Rotman 0.0275 %	205,600	0.0275 %	267 $
Adi Raviv 0.008941 %	66,800	0.008941 %	87 $
Morris Laster 0.008941 %	66,800	0.008941 %	87 $
Yael Margolin 0.008941 %	66,800	0.008941 %	87 $
Samuel Moed 0.000000 %	0	0.000000 %	- $
Jay Green 0.000000 %	0	0.000000 %	- $
Amir Reichman 0.000000 %	0	0.000000 %	- $

Scinai Immunotherapeutics Ltd.

Jerusalem BioPark Hadassah Ein Kerem Campus

74036, Jerusalem

+972 8 930 2529

http://www.biondvax.com

address Scinai Immunotherapeutics Ltd.(SCNI)

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

0.4578 USD

Average target price

70 USD

Spread / Average Target

+15,189.45%

Consensus

Company calendar

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Other Biotechnology & Medical Research

	1st Jan change	Capi.
SCINAI IMMUNOTHERAPEUTICS LTD.	-23.11%	1.99M
IQVIA HOLDINGS INC.	+1.51%	42.75B
LONZA GROUP AG	+48.32%	41.61B
MODERNA, INC.	+8.57%	41.34B
CELLTRION, INC.	-12.36%	26.59B
ICON PUBLIC LIMITED COMPANY	+8.92%	25.49B
ALNYLAM PHARMACEUTICALS, INC.	-25.13%	18.12B
MEDPACE HOLDINGS, INC.	+29.17%	12.24B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-3.12%	11.76B
UNITED THERAPEUTICS CORPORATION	+6.35%	11B

Other Biotechnology & Medical Research